Silencing of STAMP1/STEAP2 and Amplification with Apoptosis Panel Primers
DOI:
https://doi.org/10.14738/bjhr.1205.19320Keywords:
silencing of STAMP1/STEAP2, LNCaP, P53, RT-PCR, AR: Androgen receptor, ChIP: Chromatine Immunoprecipitation, RTqPCR: Quantitative polymerase chain reaction, TUBITAK: The Scientific and Technological Research Council of Turkey, STAMP: six transmembrane protein of prostate, TUBA: The Turkish Academy of SciencesAbstract
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer mortality in men in the Western World. The effects of androgens are mediated by the androgen receptor (AR). Therefore, studies focus on identification of AR regulated genes that are also highly expressed in the prostate. STAMP family genes STAMP1/STEAP2 (Korkmaz KS., 2002) and STAMP2/STEAP4 (Korkmaz CG., 2005) are only expressed in androgen receptor positive cells, the role of AR in STAMP family gene expression is an important question. STEAP (six transmembrane epithelial antigen of prostate) (Hubert RS., 1999) is the first characterized prostate enriched six transmembrane gene, expressed in metastatic prostate cancer samples, it is tempting to speculate that STAMP/STEAP family genes may be involved in similar functions with a role for both the normal biology and pathophysiology of prostate. Using siRNA technology in LNCaP cells expressing STAMP genes per se, an apoptosis panel including pro-apoptotic and/or apoptotic molecules was assayed by RT-PCR, By this research project, prostate-specific STAMP gene family and its regulatory effects were characterized.
References
Bilge Debelec-Butuner 1,2, Cansu Alapinar 1, Nursah Ertunc 1, Ceren Gonen-Korkmaz 3, Kutsal Yörükoğlu 4, Kemal Sami Korkmaz 1,* TNFα-Mediated Loss of β-Catenin/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells PLoS One. 2014 Oct 31;9(10):e109868. doi: 10.1371/journal.pone.0109868
Ceren Gonen-Korkmaz, Gulnur Sevin, Goksel Gokce, Mehmet Zuhuri Arun, Gokce Yildirim, Buket Reel, Aysegul Kaymak, Deniz Ogut. Analysis of tumor necrosis factor α-induced and nuclear factor κB- 72 Gonen, C. (2025). Silencing of STAMP1/STEAP2 and Amplification with Apoptosis Panel Primers. British Journal of Healthcare and Medical Research, silenced LNCaP prostate cancer cells by RT-qPCR, Exp Ther Med. 2014 Oct 17;8(6):1695–1700. doi: 10.3892/etm.2014.2032
Mazen Saeed, Mehmet Zuhuri Arun, Mehmet Guzeloglu, Ceylan Onursal, Goksel Gokce, Ceren Gonen Korkmaz, Buket Reel Low-dose doxycycline inhibits hydrogen peroxide-induced oxidative stress, MMP-2 up-regulation and contractile dysfunction in human saphenous vein grafts Drug Des Devel Ther. 2019; 13: 1791–1801. Published online 2019 May 23. doi: 10.2147/DDDT.S187842 PMCID: PMC6536710
CEREN GONEN, Flow Cytometry and Annexin V Marking Results, Visibility, 2023, International journal of science and research
CEREN GONEN-KORKMAZ Expression of Prostate-Specific Genes (STAMP1/STEAP2) in the Early Stages of Prostate Cancer, Journal of Cell Signaling Open Access ISSN: 2576-1471
Gönen, C. Responses Taken by Silencing of NFkappaB, STAMP1 and STAMP2 Genes and Expression of NFkB, Act-1, p53 and p73 at −/+ TNFalpha Induced LNCaP Cells. (2022) Journal of Cancer Therapy, 13, 685-700. https://doi.org/10.4236/jct.2022.1312060
CEREN GONEN, Promoter Region Analysis of STAMP1/STEAP2 Gene-Silencing of STAMP1/STEAP2 Gene Triggers P53 Upregulation. Publisher: Scientific Research Publishing. https://doi.org/10.4236/CELLBIO.2023.121001
Lorenzo PI, Arnoldussen YJ and Saatcioglu F: Molecular mechanisms of apoptosis in prostate cancer. Crit Rev Oncog. 13:1–38. 2007. View Article : Google Scholar
Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, et al: STEAP: a prostatespecific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA. 96:14523–14528. 1999. View Article : Google Scholar : PubMed/NCBI
Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL and Saatcioglu F: Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 277:36689–36696. 2002. View Article : Google Scholar : PubMed/NCBI
Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, Klokk TI, Hammarstrom C, et al: Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene. 24:4934–4945. 2005. View Article : Google cholar : PubMed/NCBI
Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, Lindstad T, Vaillancourt E, et al: Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell. 129:537–548. 2007. View Article : Google Scholar : PubMed/NCBI
Steiner MS, Zhang X, Wang Y and Lu Y: Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res. 60:4419–4425. 2000.PubMed/NCBI
Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, et al: The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA. 100:2284–2289. 2003. View Article : Google Scholar : PubMed/NCBI
Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Maelandsmo GM, Kristian A, et al: STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer. Cancer Res. 70:5818–5828. 2010. View Article : Google Scholar : PubMed/NCBI
Galluzzi L, Morselli E, Kepp O, Tajeddine N and Kroemer G: Targeting p53 to mitochondria for cancer therapy. Cell Cycle. 7:1949–1955. 2008. View Article : Google Scholar : PubMed/NCBI
Wadgaonkar R and Collins T: Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression. J Biol Chem. 274:13760–13767. 1999. View Article : Google Scholar : PubMed/NCBI
Gomes IM., Maia CJ. ve Santos CR., STEAP Proteins: From Structure to Applications in Cancer. Molecular Cancer Research,2012. URL: http://dx.doi.org/10.14738/bjhr.1205.19320. 73
Steiner, M.S., Zhang, X., Wang, Y., and Lu, Y.. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer research 60 (2000), 4419-4425. 18
Passer, B.J., Nancy-Portebois, V., Amzallag, N., Prieur, S., Cans, C., Roborel de Climens, A., Fiucci, G., Bouvard, V., Tuynder, M., Susini, L., et al.. The p53- inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 2284-2289.
Ohgami, R.S., Campagna, D.R., McDonald, A., and Fleming, M.D. The Steap proteins are metalloreductases. Blood 108(2006): 1388-1394.
Thomas G. P. Grunewald, Horacio Bach, Andrea Cossarizza and Isao Matsumoto The STEAP protein family: Versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. Biol. Cell 104 (2012), 641–657 DOI: 10.1111/boc.201200027 22
Gina Manda, Gheorghita Isvoranu, Maria Victoria Comanescu, Adrian Manea, Bilge Debelec Butuner, Kemal Sami Korkmaz The redox biology network in cancer pathophysiology and therapeutics Redox Biology Volume 5, August 2015, Pages 347–357 doi:10.1016/j.redox.2015.06.014
Gonen-Korkmaz C, Sevin G, Gokce G, Arun MZ, Yetik- Anacak G, Yildirim G., Varisli L., Reel B., Kaymak A., Abdulaziz M.S., Ogut D. (2016) Role of Six Trans Membrane Protein of Prostate (STAMP) Proteins in Prostate Cancer-Relation with Survival Genes. J Cell Signal 1:114. doi:10.4172/jcs.1000114
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ceren Gonen
This work is licensed under a Creative Commons Attribution 4.0 International License.
